Education
About Us
Working with TipRanks
Follow Us
Telomir Pharmaceuticals, Inc. (TELO)
:TELO
TELO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.11 - $9.39
Previous CloseN/A
Volume44.80K
Average Volume (3M)157.04K
Market Cap
$134.82M
Enterprise ValueN/A
Total Cash (Recent Filing)$1.27M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.03
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding29,762,670
10 Day Avg. Volume208,860
30 Day Avg. Volume157,045
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)194.76
Price to Cash Flow (P/CF)-33.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$15.00Price Target Upside231.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Ownership Overview
11.06%
Insiders
4.79% Mutual Funds
0.34% Other Institutional Investors
77.66% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
TELO FAQ
What was Telomir Pharmaceuticals, Inc.’s price range in the past 12 months?
Telomir Pharmaceuticals, Inc. lowest stock price was $3.11 and its highest was $9.39 in the past 12 months.
What is Telomir Pharmaceuticals, Inc.’s market cap?
Telomir Pharmaceuticals, Inc.’s market cap is $134.82M.
When is Telomir Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Telomir Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Telomir Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Telomir Pharmaceuticals, Inc.’s price is currently Undervalued.
Does Telomir Pharmaceuticals, Inc. pay dividends?
Telomir Pharmaceuticals, Inc. does not currently pay dividends.
What is Telomir Pharmaceuticals, Inc.’s EPS estimate?
Telomir Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Telomir Pharmaceuticals, Inc. have?
Telomir Pharmaceuticals, Inc. has 29,762,670 shares outstanding.
What happened to Telomir Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Telomir Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in TELO
---
Telomir Pharmaceuticals, Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$15.00 (231.13% Upside)
$15.00 (231.13% Upside)
Hedge Fund Trend
Increased
By 6.8K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-21.80%
12-Months-Change
Fundamentals
Return on Equity
-813.12%
Trailing 12-Months
Asset Growth
-72.26%
Trailing 12-Months
Company Description
Telomir Pharmaceuticals, Inc.
Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.
---
TELO Stock 12 Month Forecast
Average Price Target
$15.00
▲(231.13% Upside)
Technical Analysis
Best Analysts Covering TELO
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+8.30%
initiated a buy rating last month
Copying Elemer Piros's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +8.30% per trade.
---